Shionogi & Co., Ltd. and Osaka University have established a joint research laboratory (research lab’s name: J...
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...
Japan headquartered Otsuka Pharmaceutical Co. has concluded an investment contract of $30 million with AN Venture Part...
With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...
Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...
US-based Bruker Corporation has announced the acquisition of Nanophoton Corporation, a pioneer focused on...
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...
The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted marketing and manufacturing authorisation for Dup...
US Centers for Disease Control and Prevention (CDC) Director Mandy Cohen has announced the opening of the new C...
Japan has approved manufacturing and marketing authorisation for the Metoject Subcutaneous Injection Pen (Methotrex...
STARmed, a South Korea-based medical device manufacturer specialising in thermal ablation technology, has announced glob...
UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...
Japan-based Shimadzu Corporation and Shimadzu Scientific Instruments (SSI) have announced the development of an innovati...
Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...
ZimVie Inc., a global life sciences leader in the dental and spine markets, has launched TSX® Implant in Japan....
BridgeBio Pharma, Inc. and Kyowa Kirin have announced a partnership wherein BridgeBio’s affiliate, QED Therapeutic...
Chugai Pharmaceutical has decided to position its research subsidiary in Singapore, Chugai Pharmabody Research...
Japan-based pharmaceutical firm Takeda and US-based Protagonist Therapeutics have inked a global license and collaborati...